APO Research

APO RESEARCH · REPORT

Pain Patches

Selected research

Market Outlook & Growth Opportunities

Global Pain Patches Market Outlook and Growth Opportunities 2026

Market perspective

The global Pain Patches market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pain Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pain Patches market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pain Patches market include Sanofi, Novartis, GlaxoSmithKline, Viatris, Teva Pharmaceutical Industries, Teikoku Seiyaku, Nichiban, Mentholatum and Johnson & Johnson Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pain Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pain Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pain Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pain Patches market size, projected growth trends, production technologies, key applications, and end-use industries.

Pain Patches Segment by Company

Sanofi

Novartis

GlaxoSmithKline

Viatris

Teva Pharmaceutical Industries

Teikoku Seiyaku

Nichiban

Mentholatum

Johnson & Johnson Services

Hisamitsu Pharmaceutical

Pain Patches Segment by Type

Buprenorphine

Fentanyl

Pain Patches Segment by Application

Hospital Pharmacies

Retail Pharmacies

Online pharmacies

Pain Patches Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pain Patches status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pain Patches market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pain Patches significant trends, drivers, influence factors in global and regions.

6. To analyze Pain Patches competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pain Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pain Patches market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pain Patches industry.

Chapter 3: Detailed analysis of Pain Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pain Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pain Patches in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pain Patches Industry Trends Table 2. Pain Patches Industry Drivers Table 3. Pain Patches Industry Opportunities and Challenges Table 4. Pain Patches Industry Restraints Table 5. Global Pain Patches Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pain Patches Revenue Share by Company (2021-2026) Table 7. Global Pain Patches Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pain Patches Sales Volume Share by Company (2021-2026) Table 9. Global Pain Patches Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pain Patches Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pain Patches Key Company Manufacturing Base & Headquarters Table 12. Global Pain Patches Company, Product Type & Application Table 13. Global Pain Patches Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pain Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Buprenorphine Table 18. Significant Companies of Fentanyl Table 19. Global Pain Patches Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pain Patches Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Pain Patches Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Pain Patches Sales Volume Share by Type (2021-2026) Table 23. Global Pain Patches Sales Volume Share by Type (2027-2032) Table 24. Global Pain Patches Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pain Patches Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pain Patches Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pain Patches Sales Value Share by Type (2021-2026) Table 28. Global Pain Patches Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacies Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Online pharmacies Table 32. Global Pain Patches Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pain Patches Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Pain Patches Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Pain Patches Sales Volume Share by Application (2021-2026) Table 36. Global Pain Patches Sales Volume Share by Application (2027-2032) Table 37. Global Pain Patches Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pain Patches Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pain Patches Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pain Patches Sales Value Share by Application (2021-2026) Table 41. Global Pain Patches Sales Value Share by Application (2027-2032) Table 42. Global Pain Patches Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pain Patches Sales by Region (2021-2026) & (K Units) Table 44. Global Pain Patches Sales Market Share by Region (2021-2026) Table 45. Global Pain Patches Sales by Region (2027-2032) & (K Units) Table 46. Global Pain Patches Sales Market Share by Region (2027-2032) Table 47. Global Pain Patches Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pain Patches Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pain Patches Sales Value Share by Region (2021-2026) Table 50. Global Pain Patches Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pain Patches Sales Value Share by Region (2027-2032) Table 52. Global Pain Patches Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Pain Patches Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Pain Patches Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Pain Patches Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pain Patches Sales by Country (2021-2026) & (K Units) Table 57. Global Pain Patches Sales Market Share by Country (2021-2026) Table 58. Global Pain Patches Sales by Country (2027-2032) & (K Units) Table 59. Global Pain Patches Sales Market Share by Country (2027-2032) Table 60. Global Pain Patches Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pain Patches Sales Value Market Share by Country (2021-2026) Table 62. Global Pain Patches Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pain Patches Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sanofi Pain Patches Product Portfolio Table 68. Sanofi Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Novartis Pain Patches Product Portfolio Table 73. Novartis Recent Development Table 74. GlaxoSmithKline Company Information Table 75. GlaxoSmithKline Business Overview Table 76. GlaxoSmithKline Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GlaxoSmithKline Pain Patches Product Portfolio Table 78. GlaxoSmithKline Recent Development Table 79. Viatris Company Information Table 80. Viatris Business Overview Table 81. Viatris Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Viatris Pain Patches Product Portfolio Table 83. Viatris Recent Development Table 84. Teva Pharmaceutical Industries Company Information Table 85. Teva Pharmaceutical Industries Business Overview Table 86. Teva Pharmaceutical Industries Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Teva Pharmaceutical Industries Pain Patches Product Portfolio Table 88. Teva Pharmaceutical Industries Recent Development Table 89. Teikoku Seiyaku Company Information Table 90. Teikoku Seiyaku Business Overview Table 91. Teikoku Seiyaku Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Teikoku Seiyaku Pain Patches Product Portfolio Table 93. Teikoku Seiyaku Recent Development Table 94. Nichiban Company Information Table 95. Nichiban Business Overview Table 96. Nichiban Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Nichiban Pain Patches Product Portfolio Table 98. Nichiban Recent Development Table 99. Mentholatum Company Information Table 100. Mentholatum Business Overview Table 101. Mentholatum Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mentholatum Pain Patches Product Portfolio Table 103. Mentholatum Recent Development Table 104. Johnson & Johnson Services Company Information Table 105. Johnson & Johnson Services Business Overview Table 106. Johnson & Johnson Services Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Johnson & Johnson Services Pain Patches Product Portfolio Table 108. Johnson & Johnson Services Recent Development Table 109. Hisamitsu Pharmaceutical Company Information Table 110. Hisamitsu Pharmaceutical Business Overview Table 111. Hisamitsu Pharmaceutical Pain Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hisamitsu Pharmaceutical Pain Patches Product Portfolio Table 113. Hisamitsu Pharmaceutical Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Pain Patches Distributors List Table 117. Pain Patches Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Pain Patches Product Image Figure 2. Global Pain Patches Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pain Patches Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pain Patches Sales (2021-2032) & (K Units) Figure 5. Global Pain Patches Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pain Patches Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Buprenorphine Image Figure 10. Fentanyl Image Figure 11. Global Pain Patches Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pain Patches Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pain Patches Sales Volume Share by Type (2021-2032) Figure 14. Global Pain Patches Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pain Patches Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pain Patches Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Retail Pharmacies Image Figure 19. Online pharmacies Image Figure 20. Global Pain Patches Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pain Patches Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pain Patches Sales Volume Share by Application (2021-2032) Figure 23. Global Pain Patches Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pain Patches Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pain Patches Sales Value Share by Application (2021-2032) Figure 26. Global Pain Patches Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Pain Patches Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pain Patches Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pain Patches Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pain Patches Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pain Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pain Patches Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pain Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pain Patches Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pain Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pain Patches Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pain Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pain Patches Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pain Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pain Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pain Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pain Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Pain Patches Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Pain Patches Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Buprenorphine
  • Fentanyl
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online pharmacies
Companies covered
  • Sanofi
  • Novartis
  • GlaxoSmithKline
  • Viatris
  • Teva Pharmaceutical Industries
  • Teikoku Seiyaku
  • Nichiban
  • Mentholatum
  • Johnson & Johnson Services
  • Hisamitsu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pain Patches Sales Value (2021-2032)
  4. 1.2.2 Global Pain Patches Sales Volume (2021-2032)
  5. 1.2.3 Global Pain Patches Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pain Patches Market Dynamics
  1. 2.1 Pain Patches Industry Trends
  2. 2.2 Pain Patches Industry Drivers
  3. 2.3 Pain Patches Industry Opportunities and Challenges
  4. 2.4 Pain Patches Industry Restraints
3 Pain Patches Market by Company
  1. 3.1 Global Pain Patches Company Revenue Ranking in 2025
  2. 3.2 Global Pain Patches Revenue by Company (2021-2026)
  3. 3.3 Global Pain Patches Sales Volume by Company (2021-2026)
  4. 3.4 Global Pain Patches Average Price by Company (2021-2026)
  5. 3.5 Global Pain Patches Company Ranking (2024-2026)
  6. 3.6 Global Pain Patches Company Manufacturing Base and Headquarters
  7. 3.7 Global Pain Patches Company Product Type and Application
  8. 3.8 Global Pain Patches Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pain Patches Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pain Patches Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pain Patches Market by Type
  1. 4.1 Pain Patches Type Introduction
  2. 4.1.1 Buprenorphine
  3. 4.1.2 Fentanyl
  4. 4.2 Global Pain Patches Sales Volume by Type
  5. 4.2.1 Global Pain Patches Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pain Patches Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pain Patches Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pain Patches Sales Value by Type
  9. 4.3.1 Global Pain Patches Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pain Patches Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pain Patches Sales Value Share by Type (2021-2032)
5 Pain Patches Market by Application
  1. 5.1 Pain Patches Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Online pharmacies
  5. 5.2 Global Pain Patches Sales Volume by Application
  6. 5.2.1 Global Pain Patches Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pain Patches Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pain Patches Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pain Patches Sales Value by Application
  10. 5.3.1 Global Pain Patches Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pain Patches Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pain Patches Sales Value Share by Application (2021-2032)
6 Pain Patches Regional Sales and Value Analysis
  1. 6.1 Global Pain Patches Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pain Patches Sales by Region (2021-2032)
  3. 6.2.1 Global Pain Patches Sales by Region: 2021-2026
  4. 6.2.2 Global Pain Patches Sales by Region (2027-2032)
  5. 6.3 Global Pain Patches Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pain Patches Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pain Patches Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pain Patches Sales Value by Region (2027-2032)
  9. 6.5 Global Pain Patches Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pain Patches Sales Value (2021-2032)
  12. 6.6.2 North America Pain Patches Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pain Patches Sales Value (2021-2032)
  15. 6.7.2 Europe Pain Patches Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pain Patches Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pain Patches Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pain Patches Sales Value (2021-2032)
  21. 6.9.2 South America Pain Patches Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pain Patches Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pain Patches Sales Value Share by Country, 2025 VS 2032
7 Pain Patches Country-level Sales and Value Analysis
  1. 7.1 Global Pain Patches Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pain Patches Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pain Patches Sales by Country (2021-2032)
  4. 7.3.1 Global Pain Patches Sales by Country (2021-2026)
  5. 7.3.2 Global Pain Patches Sales by Country (2027-2032)
  6. 7.4 Global Pain Patches Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pain Patches Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pain Patches Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pain Patches Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pain Patches Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pain Patches Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pain Patches Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pain Patches Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pain Patches Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pain Patches Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pain Patches Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pain Patches Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pain Patches Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pain Patches Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pain Patches Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pain Patches Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pain Patches Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pain Patches Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pain Patches Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pain Patches Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pain Patches Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pain Patches Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pain Patches Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pain Patches Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pain Patches Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pain Patches Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pain Patches Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pain Patches Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pain Patches Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pain Patches Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pain Patches Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pain Patches Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pain Patches Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pain Patches Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pain Patches Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pain Patches Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pain Patches Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pain Patches Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pain Patches Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pain Patches Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pain Patches Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pain Patches Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pain Patches Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pain Patches Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pain Patches Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pain Patches Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pain Patches Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pain Patches Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pain Patches Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pain Patches Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pain Patches Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pain Patches Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pain Patches Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pain Patches Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pain Patches Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pain Patches Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pain Patches Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pain Patches Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pain Patches Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pain Patches Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pain Patches Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pain Patches Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pain Patches Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pain Patches Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pain Patches Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pain Patches Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pain Patches Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pain Patches Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pain Patches Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pain Patches Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pain Patches Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pain Patches Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pain Patches Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pain Patches Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pain Patches Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pain Patches Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pain Patches Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pain Patches Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pain Patches Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pain Patches Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pain Patches Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pain Patches Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pain Patches Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pain Patches Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pain Patches Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pain Patches Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pain Patches Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Pain Patches Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Pain Patches Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Pain Patches Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Pain Patches Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Pain Patches Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Pain Patches Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Viatris
  20. 8.4.1 Viatris Company Information
  21. 8.4.2 Viatris Business Overview
  22. 8.4.3 Viatris Pain Patches Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Viatris Pain Patches Product Portfolio
  24. 8.4.5 Viatris Recent Developments
  25. 8.5 Teva Pharmaceutical Industries
  26. 8.5.1 Teva Pharmaceutical Industries Company Information
  27. 8.5.2 Teva Pharmaceutical Industries Business Overview
  28. 8.5.3 Teva Pharmaceutical Industries Pain Patches Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Teva Pharmaceutical Industries Pain Patches Product Portfolio
  30. 8.5.5 Teva Pharmaceutical Industries Recent Developments
  31. 8.6 Teikoku Seiyaku
  32. 8.6.1 Teikoku Seiyaku Company Information
  33. 8.6.2 Teikoku Seiyaku Business Overview
  34. 8.6.3 Teikoku Seiyaku Pain Patches Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Teikoku Seiyaku Pain Patches Product Portfolio
  36. 8.6.5 Teikoku Seiyaku Recent Developments
  37. 8.7 Nichiban
  38. 8.7.1 Nichiban Company Information
  39. 8.7.2 Nichiban Business Overview
  40. 8.7.3 Nichiban Pain Patches Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nichiban Pain Patches Product Portfolio
  42. 8.7.5 Nichiban Recent Developments
  43. 8.8 Mentholatum
  44. 8.8.1 Mentholatum Company Information
  45. 8.8.2 Mentholatum Business Overview
  46. 8.8.3 Mentholatum Pain Patches Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Mentholatum Pain Patches Product Portfolio
  48. 8.8.5 Mentholatum Recent Developments
  49. 8.9 Johnson & Johnson Services
  50. 8.9.1 Johnson & Johnson Services Company Information
  51. 8.9.2 Johnson & Johnson Services Business Overview
  52. 8.9.3 Johnson & Johnson Services Pain Patches Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Services Pain Patches Product Portfolio
  54. 8.9.5 Johnson & Johnson Services Recent Developments
  55. 8.10 Hisamitsu Pharmaceutical
  56. 8.10.1 Hisamitsu Pharmaceutical Company Information
  57. 8.10.2 Hisamitsu Pharmaceutical Business Overview
  58. 8.10.3 Hisamitsu Pharmaceutical Pain Patches Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hisamitsu Pharmaceutical Pain Patches Product Portfolio
  60. 8.10.5 Hisamitsu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pain Patches Value Chain Analysis
  2. 9.1.1 Pain Patches Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pain Patches Sales Mode & Process
  6. 9.2 Pain Patches Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pain Patches Distributors
  9. 9.2.3 Pain Patches Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research